z-logo
Premium
A 1 and A 2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea‐pig
Author(s) -
Haynes John M,
Alexander S P H,
Hill Stephen J
Publication year - 1998
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702095
Subject(s) - adenosine , medicine , endocrinology , phenylephrine , agonist , adenosine receptor , contractility , adenosine a1 receptor , chemistry , receptor , biology , blood pressure
1 The effects of adenosine receptor agonists upon phenylephrine‐stimulated contractility and [ 3 H]‐cyclic adenosine monophosphate ([ 3 H]‐cyclic AMP) accumulation in the cauda epididymis of the guinea‐pig were investigated. The α 1 ‐adrenoceptor agonist, phenylephrine elicited concentration dependent contractile responses from preparations of epididymis. In the absence or presence of the L‐type Ca 2+ channel blocker, nifedipine (10 μ M ) the non‐selective adenosine receptor agonist, 5′‐N‐ethylcarboxamido‐adenosine (NECA, 1 μ M ) shifted phenylephrine concentration‐response curves to the left (4 and 5 fold respectively). Following the incubation of preparations with pertussis toxin (200 ng ml −1 24 h) NECA shifted phenylephrine concentration‐response curves to the right (5.7±0.9 fold). 2 In the presence of phenylephrine (1 μ M ), NECA and the A 1 adenosine receptor selective agonists, N 6 ‐cyclopentyladenosine (CPA) and (2S)‐N 6 ‐[2‐endo‐norbornyl]adenosine ((S)‐ENBA) elicited concentration‐responses dependent contractions from preparations of epididymis (pEC 50 values 8.18±0.19, 7.79±0.29 and 8.15±0.43 respectively). The A 3 adenosine receptor agonists N 6 ‐iodobenzyl‐5′‐N‐methyl‐carboxamido adenosine (IBMECA) and N 6 ‐2‐(4‐aminophenyl) ethyladenosine (APNEA) mimicked this effect (but only at concentrations greater than 10 μ M ). In the presence of 8‐cyclopentyl‐1,3‐dipropylxanthine (DPCPX, 30 n M ) CPA concentration‐response curves were shifted, in parallel to the right (apparent pK B 8.75±0.88) and the maximal response to NECA was reduced. 3 In the presence of DPCPX (100 n M ) the adenosine agonist NECA and the A 2A adenosine receptor selective agonist, CGS 21680 (2‐ p ‐(2‐carboxyethyl)‐phenethylamino‐N‐ethylcarboxamido adenosine), but not CPA, inhibited phenylephrine (20 μ M ) stimulated contractions (pIC 50 7.15±0.48). This effect of NECA was blocked by xanthine amine congener (XAC, 1 μ M ) and the A 2A adenosine receptor‐selective antagonist 4‐(2‐[7‐amino‐2‐(2‐furyl)[1,2,4]triazolo[2,3‐a][1,3,5]triazin‐5‐ylamino]ethyl)phenol (ZM 241385; 30 n M ). 4 (S)‐ENBA (in the absence and presence of ZM 241385, 100 n M ), but not NECA or CPA inhibited the forskolin (30 μ M )‐stimulated accumulation of [ 3 H]‐cyclic AMP in preparations of the epididymis of the guinea‐pig (by 17±6% of control). In the presence of DPCPX (100 n M ) NECA and CGS 21680, but not (S)‐ENBA, increased the accumulation of [ 3 H]‐cyclic AMP in preparations of epididymis (pEC 50 values 5.35±0.35 and 6.42±0.40 respectively), the NECA‐induced elevation of [ 3 H]‐cyclic AMP was antagonised by XAC (apparent pK B 6.88±0.88) and also by the A 2A adenosine receptor antagonist, ZM 241385 (apparent pK B 8.60± 0.76). 5 These studies are consistent with the action of stable adenosine analogues at post‐junctional A 1 and A 2 adenosine receptors in the epididymis of the guinea‐pig. A 1 Adenosine receptors potentiate α 1 ‐adrenoceptor contractility, an effect blocked by pertussis toxin, but which may not be dependent upon an inhibition of adenylyl cyclase. The epididymis of the guinea‐pig also contains A 2 adenosine receptors, possibly of the A 2A subtype, which both inhibit contractility and also stimulate adenylyl cyclase.British Journal of Pharmacology (1998) 125 , 570–576; doi: 10.1038/sj.bjp.0702095

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom